glp-1 shortage The promise and peril of agonists: What we do (and don't) know as of August 2024 What happens when demand outpaces

Drug-evoked synaptic plasticity in addiction: from molecular changes to circuit remodeling

Identifying molecular or imaging biomarkers in this patient population could facilitate earlier diagnosis, enable targeted interventions, and support the monitoring of disease progression

Browse all Peptides & GLP-1 education Medical and Editorial Standards Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims

Comprehensive obesity and diabetes management extends beyond pharmacotherapy, incorporating medical nutrition therapy, physical activity (150 minutes weekly of moderate-intensity exercise), behavioral counseling, and treatment of comorbidities

It is unknown whether Ozempic causes thyroid C-cell tumors in humans